Eventide Asset Management - BOLT BIOTHERAPEUTICS INC ownership

BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 71 filers reported holding BOLT BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of BOLT BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2022$2,356,000
-66.8%
859,826
-40.7%
0.04%
-59.3%
Q4 2021$7,103,000
+5.2%
1,449,494
+171.4%
0.09%
+2.2%
Q3 2021$6,755,000
-18.2%
534,0000.0%0.09%
-19.8%
Q2 2021$8,256,000
-22.3%
534,000
+65.4%
0.11%
-29.3%
Q1 2021$10,628,000322,9440.16%
Other shareholders
BOLT BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$29,242,00011.52%
Nan Fung Group Holdings Ltd 1,166,952$18,041,0005.60%
Novo Holdings A/S 4,503,991$69,632,0003.09%
Vivo Capital, LLC 3,871,291$59,850,0002.59%
Sofinnova Investments, Inc. 2,754,437$42,584,0002.45%
Ally Bridge Group (NY) LLC 412,267$6,374,0001.58%
Samsara BioCapital, LLC 737,459$11,401,0001.41%
Board of Trustees of The Leland Stanford Junior University 719,546$11,125,0001.04%
RA Capital Management 2,378,325$36,769,0000.59%
Rock Springs Capital Management LP 1,619,248$25,034,0000.50%
View complete list of BOLT BIOTHERAPEUTICS INC shareholders